Pilar Regueiro

Capecitabine (Xeloda®) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors

Eduardo Díaz‐Rubio, T.R. Jeffry Evans, Josep Tabernero et al. · Annals of Oncology · 2002 · 109 citations

Dose-escalation Study, Oncology, Medicine +9

Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study

Javier Cortés, Serena Di Cosimo, M.Á. Climent et al. · Clinical Cancer Research · 2008 · 61 citations

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer

N. Batista, G. Pérez-Manga, Manuel Constenla et al. · British Journal of Cancer · 2004 · 48 citations · Full text

Results of a phase II study of liposomal doxorubicin (Myocet®) in combination with weekly paclitaxel and trastuzumab (Herceptin®) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

José Baselga, M.Á. Climent, Aňa Lluch et al. · European Journal of Cancer Supplements · 2004 · 24 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +9

Solubilization of Myelin Membranes by Detergents

Marta I. Aveldaño, R. S. Díaz, Pilar Regueiro et al. · Journal of Neurochemistry · 1991 · 18 citations